LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab (Q46845332)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab |
scientific article |
Statements
1 reference
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab (English)
1 reference
1 reference
1 reference
Robert Tibshirani
1 reference
Randy D Gascoyne
1 reference
Joseph M Connors
1 reference
Izidore S Lossos
1 reference
Laurie H Sehn
1 reference
Ronald Levy
1 reference
Yasodha Natkunam
1 reference
Eric D Hsi
1 reference
Christine P Hans
1 reference
Manuel Rosado
1 reference
Shuchun Zhao
1 reference
Brad Pohlman
1 reference
Nicholas Wongchaowart
1 reference
Martin Bast
1 reference
Abraham Avigdor
1 reference
Ginette Schiby
1 reference
Arnon Nagler
1 reference
Gerald E Byrne
1 reference
17 December 2007
1 reference
1 reference
26
1 reference
3
1 reference
447-454
1 reference
Identifiers
1 reference
1 reference